Morphology, Immunohistochemistry, and Genetic Alterations in Dog Astrocytomas

Veterinary Pathology

Volumn 41, Issue 1, 2004, Pages 10-19

  Stoica, G ^a   Kim, H T ^a   Hall, D G ^b   Coates, J R ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY SYSTEM   (United States)

Author keywords

Dog astrocytoma; Genetic alterations; Morphology

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG DISEASE; FEMALE; GENE EXPRESSION; GENETIC DISORDER; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MICROSCOPY; MORPHOLOGY; NONHUMAN;

ANIMALS; ASTROCYTOMA; BASE SEQUENCE; BRAIN NEOPLASMS; DNA PRIMERS; DOG DISEASES; DOGS; GENES, ERBB-1; GENES, P53; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; POINT MUTATION; SEQUENCE ANALYSIS, DNA;

ANIMALIA; CANIS FAMILIARIS;

EID: 0742304739     PISSN: 03009858     EISSN: None     Source Type: Journal    
DOI: 10.1354/vp.41-1-10     Document Type: Article

References (47)

1. Bailey P, Cushing H: In a Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study and Prognosis. JB Lippinicott, Philadelphia, PA, 1926
2. Barker FG, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, Wara WM, Berger MS, Chen P, Israel MA, Aldape KD: EGFR over expression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51:410-418, 2001
3. Bian XW, Shi JQ, Liu FX: Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors. Anal Quant Cytol Histol 22(6):429-437, 2000
4. Braund KG: Neoplasia of the nervous system. In: Clinical Neurology in Small Animals - Localization, Diagnosis and Treatment, ed. Braund KG. International Veterinary Information Service (www.ivis.org), Ithaca, NY, 2001
5. Burger PC, Vogel FS, Green SB, Strike TA: Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 56:1106-1111, 1985
6. Chakravarti A, Chakladar A, Delaney MA, Latham DE, Loeffler JS: The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Cancer Res 62(15):4307-4315, 2002
7. Curran WJ Jr, Scott CB, Yung WKA: Imaging response is highly predictive of survival of malignant glioma patients treated with standard or hyperfractionated RT and carmustine in RTOG 9006. Int J Radiat Oncol Biol Phys 36:160, 1996 [Abstract]
8. Duniho S, Schulman FY, Morrison A, Mena H, Koestner A: A subependymal giant cell astrocytoma in a cat. Vet Pathol 37:275-278, 2000
9. Ernst H, Walter GF, Dasenbrock C, Dungworth DL, Mohr U: Giant cell glioblastoma in a Syrian hamster. Vet Pathol 28:538-540, 1991
10. Foster ES, Carrillo MJ, Patnaik AK: Clinical signs of tumors affecting the rostral cerebrum in 43 dogs. J Vet Intern Med 2:71-74, 1988
11. Frenier LS, Kraft SL, Moore MP, Gavin PR: Canine intracranial astrocytomas and comparison with the human counterpart. Contin Educ 12(10):1422-1433, 1990
12. Gavin PR, Fike JR, Hoopes JP: Central nervous system tumors. Semin Vet Med Surg (Small Anim) 10(3):180-189, 1995
13. Heidner GL, Kornegay JN, Page LR, Dodge RK, Thrall DE: Analysis of survival in a retrospective study of 86 dogs with brain tumors. J Vet Intern Med 5:219-226, 1991
14. Johnson GC: Genesis and pathology of tumors of the nervous system. Semin Vet Med Surg (Small Anim) 5(4):210-222, 1990
15. Johnson SA, Couto GC, Weghorst XM: Mutation of the p53 tumor suppressor gene spontaneously occurring osteosarcomas of the dog. Carcinogenesis 19:213-217, 1998
16. Kleihues P, Cavenee WK, ed.: Pathology and Genetics of Tumors of the Nervous System, pp. 2-10. IARC, Lyon, France, 1997
17. Koestner A, Bilzer T, Schulman FY, Summers BA, Winkle Van TJ: World Health Organization. International Classification of tumor of Domestic Animals. Histological Classification of Tumors of the Nervous System of Domestic Animals. Armed Forced Institute of Pathology, American Registry of Pathology, Washington, DC, 1999
18. Kornegay JN: Central nervous system neoplasia. In: Contemporary Issues in Small Animal Practice: Neurologic Disorders, ed. Kornegay JN, pp. 79-108. Churchill Livingstone, New York, NY, 1986
19. Korshunov A, Golanov A, Sycheva R, Pronin I: Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. J Clin Pathol 52:574-580, 1999
20. Kraegel SA, Pazzi KA, Madewell BR: Sequence analysis of canine p53 in the region of exon 3-8. Can Lett 92: 181-186, 1995
21. Kujas M, Faillot T, Lalam T, Roncier B, Catala M, Poirier J: Astroblastomas revisited. Report of two cases with immunohistochemical and electron microscopy study. Histogenetic considerations. Corr Neuropathol Appl Neurobiol 26:295-300, 2000
22. Laerum OD, Nygaar SJ, Steine S, Mork SJ, Engebraaten O, Peraud A, Kleihues P, Ohgaki H: Invasivness in vitro and biological markers in human primary glioblastomas. J Neurooncol 54(1):1-8, 2001
23. LeCouteur RA: Brain tumors of dogs and cats. Vet Med Rep 2:332-342, 1990
24. Lenz SD, Janovitz EB, Lockridge K: An anaplastic astrocytoma (glioblastoma) in the cerebellum of a dog. Vet Pathol 28:250-252, 1991
25. Lopes MBS, VandenBerg SR: Tumor of the central nervous system. In: Diagnostic Histopathology of Tumors, ed. Fletcher CDM, vol. 2, pp. 1161-1177. Churchill Livingstone, New York, NY, 1995
26. Lukas J, Niu N, Press MF: P53 mutations and expression in breast carcinoma in situ. Am J Pathol 156:183-190, 2000
27. Milner J, Veldhoen N: Isolation of canine p53 cDNA and detailed charcterization of the full length canine p53 protein. Oncogene 16:1077-1084, 1998
28. Mineo JF, Quintin-Roue I, Lucas B, Buburusan V, Besson G: Glioblastomas: clinical study and search for prognostic factors. Neurochirurgie 48(6):500-509, 2002
29. Muto T, Wakui S, Takahashi H, Maekawa S, Masaoka T, Ushigome S, Furusato M: p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog. Vet Pathol 37:248-253, 2000
30. Nelson RW, Morrison WB, Lurus AG, Miller JB: Diencephalic syndrome secondary to intracranial astrocytoma in a dog. JAVMA 179(10): 1004-1010, 1981
31. Ohgaki H, Peraud A, Nakazato Y, Watanabe K, von Deimling A: Giant cell glioblastoma. In: Pathology and Genetics of Tumors of the Nervous System, ed. Kleihues P, Cavenee WK, pp. 40-42. IARC, Lyon, France, 1997
32. Pore N, Liu S, Haas-Kogan DA, O'Rourke DM, Maity A: PTEN mutation and EGFR regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cell by transactivating the proximal VEGF promoter. Can Res 63:236-241, 2003
33. Reis RM, Konu-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H. Genetic profile of gliosarcomas. Am J Pathol 156(2):425-432, 2000
34. Sarfaty D, Carrillo MJ, Patnaik AK. Cerebral astrocytoma in four cats: clinical and pathological findings. JAVMA 191(8):976-978, 1987
35. Smits A, Funa K. Platelet-derived growth factor (PDGF) in primary brain tumors of neuroglial origin. Histol Histopathol 13(2):511-520, 1998
36. Steinberg H, Galbreath EJ. Cerebellar medulloblastoma with multiple differentiation in a dog. Vet Pathol 35: 543-546, 1998
37. Stoica G, Tasca IS, Kim H-T: Point mutation of neu oncogene in animal peripheral nerve sheath tumors. Vet Pathol 38:679-688, 2001
38. Summers BA, Cummings JF, Alexander de Lahunta: Tumor of the Central Nervous System. In Veterinary Neuropathology, pp. 351-395. Mosby, St. Louis, MO, 1995.
39. Thomas CY, Chouinard M, Cox M, Parsons S, Stallings-Mann M, Garcia R, Jove R, Wharen R: Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. Int J Can 104(1):19-27, 2003
40. Thomas WB, Wheeler SJ, Kramer R, Kornegay JN: Magnetic resonance imaging features of primary brain tumors in dogs. Vet Radiol Ultrasound 37(1):20-27, 1996
41. Turrel JM, Fike JR, LeCouteur RA, Higgins RJ: Computed tomographic characteristics of primary brain tumors in 50 dogs. JAVMA 188(8):851-856, 1986
42. Tysnes BB, Haugland HK, Bjerkvig R: Epidermal growth factor and lamiin receptors contribute to migratory and invasive properties of gliomas. Invasion Metastasis 17(5):270-280, 1997
43. Uchida K, Kuroki K, Priosoeryanto BP, Kata K, Yano Y, Murakami T, Yamaguchi R, Tateyama S: Giant cell gioblastoma in the frontal cortex of a dog. Vet Pathol 32: 197-199, 1995
44. Vandevelde M, Frankhauser R, Luginbuhl H: Immunohistochemical studies in canine neuroectodermal tumors. Acta Neuropathol (Berl) 66:111-116, 1985
45. Veldhoen N, Stewart J, Brown R, Milner J: Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Oncogene 16:249-255, 1998
46. Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H: Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Clin Can Res 3:523-530, 1997
47. Wen W-H, Reles A, Sullivan-Haley J, Bernstein L, Jones L, El-Naggar A, Felix J, Runnembaum I, Press M: p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynaecol Oncol 18:24-41, 1999